{
    "2019-12-23": [
        [
            {
                "time": "",
                "original_text": "玻尿酸“第一股”华熙生物，退港挂牌科创板疑云重重",
                "features": {
                    "keywords": [
                        "玻尿酸",
                        "华熙生物",
                        "退港",
                        "科创板",
                        "疑云"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗",
                        "美妆"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "招商证券给予“强烈推荐-A”投资评级 全球透明质酸龙头华熙生物积极延伸医疗/美妆终端",
                "features": {
                    "keywords": [
                        "招商证券",
                        "强烈推荐-A",
                        "透明质酸",
                        "华熙生物",
                        "医疗",
                        "美妆"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗",
                        "美妆"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}